Laboratory of Pharmaceutical Technology;
Faculty of Pharmacy;
University of Coimbra;
Polo das Ci^encias da Saúde;
Azinhaga de Santa Comba;
3000-548 Coimbra;
Portugal;
Laboratory of Pharmacology;
Faculty of Pharmacy;
University of Coimbra;
Polo das Ci^encias da Saúde;
Azinhaga de Santa Comba;
3000-548 Coimbra;
Portugal;
CNC e Centre for Neuroscience and Cell Biology;
University of Coimbra;
3004-517 Coimbra;
Portugal;
REQUIMTE/LAQV;
Group of Pharmaceutical Technology;
Faculty of Pharmacy;
University of Coimbra;
Polo das Ci^encias da Saúde;
Azinhaga de Santa Comba;
3000-548 Coimbra;
Portugal;
Laboratory of Physiology;
IBILI;
Faculty of Medicine;
University of Coimbra;
Polo das Ci^enicas da Saúde;
Azinhaga de Sante Comba;
300-548 Coimbra;
Portugal;
Pharmaceutical Development;
TECNIMEDE;
S. A. Quinta da Cerca;
Caixaria;
2565-187 Dois Portos;
Portugal;
I3S;
Instituto de Investiga鐍ao e Inova鐍ao em Sa鷇e;
Group Genetics of Cognitive Dysfunction;
IBMC e Instituto de Biologia Molecular e Celular;
Rua do Campo Alegre 823;
4150-180 Porto;
Portugal;
Type; 2; diabetes; Exenatide; Therapeutic; drug; monitoring; ELISA; HPLC;